Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 2
2016 2
2017 1
2018 1
2020 3
2021 6
2022 7
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O. Gur C, et al. Among authors: cuapio a. Immunity. 2015 Feb 17;42(2):344-355. doi: 10.1016/j.immuni.2015.01.010. Epub 2015 Feb 10. Immunity. 2015. PMID: 25680274 Free PMC article.
ACE2: the molecular doorway to SARS-CoV-2.
Medina-Enríquez MM, Lopez-León S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. Medina-Enríquez MM, et al. Among authors: cuapio a. Cell Biosci. 2020 Dec 30;10(1):148. doi: 10.1186/s13578-020-00519-8. Cell Biosci. 2020. PMID: 33380340 Free PMC article. Review.
Human CD56bright NK Cells: An Update.
Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, Zimmer J. Michel T, et al. Among authors: cuapio a. J Immunol. 2016 Apr 1;196(7):2923-31. doi: 10.4049/jimmunol.1502570. J Immunol. 2016. PMID: 26994304 Review.
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID.
Chen P, Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, Gao Y, Söderdahl G, Österborg A, Smith CIE, Vesterbacka J, Wullimann D, Cuapio A, Akber M, Bogdanovic G, Muschiol S, Åberg M, Loré K, Chen MS, Ljungman P, Buggert M, Aleman S, Ljunggren HG. Chen P, et al. Among authors: cuapio a. EBioMedicine. 2024 Nov;109:105385. doi: 10.1016/j.ebiom.2024.105385. Epub 2024 Oct 11. EBioMedicine. 2024. PMID: 39395230 Free PMC article. Clinical Trial.
NK cells in COVID-19-from disease to vaccination.
Hammer Q, Cuapio A, Bister J, Björkström NK, Ljunggren HG. Hammer Q, et al. Among authors: cuapio a. J Leukoc Biol. 2023 Oct 26;114(5):507-512. doi: 10.1093/jleuko/qiad031. J Leukoc Biol. 2023. PMID: 36976012 Review.
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19.
Strunz B, Maucourant C, Mehta A, Wan H, Du L, Sun D, Chen P, Nordlander A, Gao Y, Cornillet M, Bister J, Kvedaraite E, Christ W, Klingström J, Geanon D, Parke Å, Ekwall-Larson A, Rivino L, MacAry PA, Aleman S, Buggert M, Ljunggren HG, Pan-Hammarström Q, Lund-Johansen F, Strålin K, Björkström NK; Karolinska KI/K COVID-19 Study Group. Strunz B, et al. J Infect Dis. 2024 Aug 16;230(2):e318-e326. doi: 10.1093/infdis/jiae036. J Infect Dis. 2024. PMID: 38421006 Free PMC article.
29 results